関連文献

A newly developed kit for the measurement of urinary liver-type fatty acid-binding protein as a biomarker for acute kidney injury in patients with critical care.

J Infect Chemother. 21(3): 165-169, 2014.PubMed

Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury.

Kidney Int. 87(3): 640-648, 2014.PubMed

Repulsive guidance cue semaphorin 3A in urine predicts the progression of acute kidney injury in adult patients from a mixed intensive care unit.

Nephrol Dial Transplant. 29(1): 73-80, 2014.PubMed

Urinary biomarkers and progression of AKI in patients with cirrhosis.

Clin J Am Soc Nephrol. 9(11): 1857-1867, 2014.PubMed

Biomarkers of acute kidney injury in pediatric cardiac surgery.

Clin Biochem. 46(13-14): 1244-1251, 2013.PubMed

Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis.

Am J Kidney Dis. 61(3): 430-439, 2013.PubMed

Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery.

Clin J Am Soc Nephrol. 8(7): 1079-1088, 2013.PubMed

Remote Ischemic Pre-Conditioning Alleviates ContrastInduced Acute Kidney Injury in Patients With Moderate Chronic Kidney Disease.

Circulation Journal. 77(12): 3037-3044, 2013.PubMed

The role of urinary liver-type fatty acid-binding protein in critically ill patients.

J Korean Med Sci. 28(1): 100-105, 2013.PubMed

Clinical significance of the measurements of urinary liver-type fatty acid binding protein levels in patients with acute coronary syndrome.

J Cardiol. 60(3): 168-173, 2012.PubMed